Janus kinase inhibitors: a future all-rounder in axial spondyloarthritis?

Immunotherapy. 2023 Oct;15(15):1195-1198. doi: 10.2217/imt-2023-0176. Epub 2023 Sep 18.
No abstract available

Keywords: ankylosing spondylitis; axial spondyloarthritis; filgotinib; inflammatory bowel disease; janus kinase inhibitors; psoriasis; psoriatic arthritis; tofacitinib; upadacitinib; uveitis.

Publication types

  • Editorial

MeSH terms

  • Axial Spondyloarthritis*
  • Humans
  • Janus Kinase Inhibitors* / therapeutic use

Substances

  • Janus Kinase Inhibitors